Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-06-04 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2009
Regulatory Filings
2009-06-04 Danish
Regulatory Filings 2009
Regulatory Filings
2009-06-03 Danish
Board/Management Information 2009
Board/Management Information Classification · 98% confidence The document is a short announcement (692 characters) from NASDAQ OMX Copenhagen, titled "Fondsbørsmeddelelse" (Stock Exchange Announcement). The content explicitly states that a director, David Huang, is resigning and a new director, Vilhelm Boas, has been appointed. This directly relates to changes in senior management or the board of directors. This aligns perfectly with the definition for Board/Management Information (MANG). Given the short length and announcement nature, it is not a comprehensive report.
2009-06-03 English
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (245 characters) and announces a specific financial metric, 'Indre værdi' (Net Asset Value), calculated on a specific date (June 3, 2009). The format resembles a brief regulatory announcement from a stock exchange ('OMX Nordic Exchange Copenhagen'). Since the document explicitly states the calculated value rather than being a comprehensive report, and 'NAV' (Net Asset Value) is a defined category for regular updates of this metric, the classification should be NAV. It is not an announcement of a report (RPA/RNS) because it contains the core data itself, not just a pointer to a larger document.
2009-06-03 English
Regulatory Filings 2009
Regulatory Filings
2009-06-03 Danish
Regulatory Filings 2009
Regulatory Filings
2009-06-02 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.